Cancer Research

Canada's Delusional Multi-Million Dollar Investments To Cover Costs Of Personalized Cancer Drugs

...

Article - Jennifer Wong - Jan 29 2013 - 6:44pm

Sabutoclax (ONT-701) May BeThe Next Magic Bullet To Combat The Root Of Cancer

While there are many proposed “magic bullets” since the 1940s to combat cancer, more than 90% of these drug candidates fail during clinical trials. Part of the reason for this failure is because many drugs are often effective in eliminating only the bulk ...

Article - Jennifer Wong - Jan 31 2013 - 12:59pm

A Bioelectric Signal For Early Detection Of Cancer

Biologists have discovered a bioelectric signal that can identify cells that are likely to develop into tumors. The researchers also found that they could lower the incidence of cancerous cells by manipulating the electrical charge across cells' memb ...

Article - News Staff - Feb 1 2013 - 1:41pm

Stem Cell Boosting Treatments Can Reduce The Damaging Impact Of New Myeloma Drug On Patient Stem Cells

Myeloma treatments require a heavy artillery of novel myeloma drugs to reduce the number of cancer cells (ex: Revlimid, Velcade, or Thalomid), followed by high-dose chemotherapy to wipe out the cancer. Because the latter can completely wipe out blood-form ...

Article - Jennifer Wong - Feb 6 2013 - 8:03pm

Tumor Blood Vessels Orchestrate The Birth Of Cancer Stem Cells

Like blood vessels that supply oxygen and nutrients to normal tissue, tumor blood vessels were originally thought to do likewise to fuel tumor growth. As scientists developed strategies to kill tumors by cutting off their blood supply, they soon discovere ...

Article - Jennifer Wong - Feb 7 2013 - 5:49pm

Matching Tumors With The Optimal Cancer Drugs

In a new paper,  researchers assess the complete landscape of a cancer's kinome expression and determine which kinases are acting up in a particular tumor.  Since the proteins are relatively easy to target with drugs and plenty of kinase inhibitors a ...

Article - News Staff - Feb 6 2013 - 2:42pm

Micro RNA 506 Blocks Ovarian Cancer Cells

Researchers employing an extensive analysis of genomic information have identified micro RNA 506 (miR-506) as a potential therapeutic candidate for advanced or metastatic ovarian cancer situations. This high-risk cohort of ovarian cancer patients can be t ...

Article - News Staff - Feb 11 2013 - 4:20pm

A Breakthrough In Ovarian Cancer

Researchers have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib, according to a paper in The Lancet Oncology which sh ...

Article - News Staff - Feb 14 2013 - 8:00pm

Omega-3 Fatty Acids Stunt Breast Cancer Tumors In Study

A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumors by 30 percent, according to new research published in the Journal of Nutritional Biochemistry, which they say is the first to provide unequivocal evidence that omega-3s ...

Article - News Staff - Feb 21 2013 - 11:16am

New Immunptherapy Like A Cancer 'Vaccine' For Metastatic Cancers

Preclinical, laboratory studies suggest immunotherapy could potentially work like a vaccine against metastatic cancers. Results from the recent study show the therapy could treat metastatic cancers and be used in combination with current cancer therapies ...

Article - News Staff - Feb 27 2013 - 12:30pm